|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
OB: Magnesium Sulfate and Cerebral Palsy, Part DeuxFrom: art fougner, md (evsono@pipeline.com)Thu Aug 28 07:08:22 2008
>From Bloomberg News: A drug commonly used to prevent premature labor in pregnant women may also reduce the risk that their infants will develop cerebral palsy, researchers said. A review of health records more than a decade ago suggested that premature newborns whose mothers were treated with magnesium sulfate were less likely to have cerebral palsy, a neurological disorder that affects muscle tone and hampers movement and posture. http://www.bloomberg.com/apps/news?pid=20601202&sid=aAmLHFNK5Lbs&refer=healthcare Original article in NEJM here: http://content.nejm.org/cgi/content/short/359/9/895 But wait, I thought Magnesium sulfate increased adverse neonatal outcomes. http://www.ajog.org/article/S0002-9378(02)00003-0/abstract Once again, the parking on the left is now the parking on the right. Medicine swings like a pendulum do. Art
-- art fougner, md "May The Wings of Liberty Never Lose a Feather." - Jack Burton
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 05:11:59 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.